Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Despite the constant improvement of therapeutical options, heart failure (HF) remains associated with high mortality and morbidity. While new developments in guideline-recommended therapies can prolong survival and postpone HF hospitalizations, impaired exercise capacity remains one of the most debi...

Descripción completa

Detalles Bibliográficos
Autores principales: Voorrips, Suzanne N., Saucedo-Orozco, Huitzilihuitl, Sánchez-Aguilera, Pablo I., De Boer, Rudolf A., Van der Meer, Peter, Westenbrink, B. Daan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369142/
https://www.ncbi.nlm.nih.gov/pubmed/35955784
http://dx.doi.org/10.3390/ijms23158631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369142/
https://www.ncbi.nlm.nih.gov/pubmed/35955784
http://dx.doi.org/10.3390/ijms23158631

Ejemplares similares